Koers Neurometrix Inc Nasdaq
Aandelen
US6412553025
Medische apparatuur, benodigdheden & distributie
Omzet 2022 | 8,26 mln. 7,67 mln. | Omzet 2023 | 5,9 mln. 5,48 mln. | Marktkapitalisatie | 3,87 mln. 3,59 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -4 mln. -3,72 mln. | Nettowinst (verlies) 2023 | -6 mln. -5,58 mln. | EV/omzet 2022 | -1,12 x |
Nettoliquiditeiten 2022 | 20,84 mln. 19,37 mln. | Nettoliquiditeiten 2023 | 17,76 mln. 16,5 mln. | EV/omzet 2023 | -2,35 x |
K/w-verhouding 2022 |
-2,41
x | K/w-verhouding 2023 |
-0,57
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 0% |
Recentste transcriptie over Neurometrix Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Shai Gozani
CEO | Chief Executive Officer | 59 | 01-06-96 |
Thomas Higgins
DFI | Director of Finance/CFO | 72 | 10-09-09 |
Brandi Damkier
PRN | Corporate Officer/Principal | - | 10-01-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Nancy Katz
BRD | Director/Board Member | 65 | 17-12-10 |
David Goodman
BRD | Director/Board Member | 67 | 01-06-04 |
Shai Gozani
CEO | Chief Executive Officer | 59 | 01-06-96 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-3,79% | 184 mld. | |
-0,84% | 108 mld. | |
-3,75% | 67,8 mld. | |
+3,45% | 51,05 mld. | |
+9,04% | 44,67 mld. | |
+3,40% | 41,78 mld. | |
+3,66% | 26,59 mld. | |
+3,21% | 26,78 mld. | |
+15,23% | 25,86 mld. |